IL6 and breast carcinoma: The results indicate that the GPR30 receptor is involved in cell proliferation induced by IL-6 and E2 in breast cancer and IL-6-induced metastatic properties, such as migration and invasion in luminal, TMX-resistant, and triple-negative cancer cells.